{
    "1734114369699471443": {
        "attachments": {
            "media_keys": [
                "13_1734114343879340032"
            ]
        },
        "author_id": "5383942",
        "created_at": "2023-12-11T07:34:18.000Z",
        "edit_history_tweet_ids": [
            "1734114369699471443"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 62,
                    "normalized_text": "European Commission",
                    "probability": 0.8203,
                    "start": 44,
                    "type": "Organization"
                }
            ],
            "hashtags": [
                {
                    "end": 5,
                    "start": 0,
                    "tag": "News"
                },
                {
                    "end": 20,
                    "start": 10,
                    "tag": "Investors"
                },
                {
                    "end": 31,
                    "start": 25,
                    "tag": "Media"
                }
            ],
            "urls": [
                {
                    "description": "At GSK, we unite science, technology and talent to get ahead of disease together",
                    "display_url": "gsk.to/3thFmmA",
                    "end": 182,
                    "expanded_url": "https://gsk.to/3thFmmA",
                    "start": 159,
                    "status": 200,
                    "title": "Home | GSK",
                    "unwound_url": "https://www.gsk.com/en-gb/?linkId=100000230648660",
                    "url": "https://t.co/3rnUs3FYaA"
                },
                {
                    "display_url": "pic.twitter.com/VlJNitH2v5",
                    "end": 206,
                    "expanded_url": "https://twitter.com/GSK/status/1734114369699471443/video/1",
                    "media_key": "13_1734114343879340032",
                    "start": 183,
                    "url": "https://t.co/VlJNitH2v5"
                }
            ]
        },
        "id": "1734114369699471443",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 2581,
            "like_count": 7,
            "quote_count": 0,
            "reply_count": 1,
            "retweet_count": 3
        },
        "text": "#News for #Investors and #Media: Today, the European Commission granted authorisation for a new indication for our immuno-oncology therapy. \n\nLearn more here: https://t.co/3rnUs3FYaA https://t.co/VlJNitH2v5"
    }
}